QUOTE AND NEWS
Benzinga  Mar 25  Comment 
On March 25, 2016, Opexa Therapeutics, Inc. (NASDAQ: OPXA) entered into that certain Sales Agreement (the "Agreement") with IFS Securities, Inc. (doing business as Brinson Patrick, a division of IFS Securities, Inc.) (the "Sales Agent"), under...
newratings.com  Mar 16  Comment 
NORTH CHICAGO (dpa-AFX) - An independent panel of experts convened by the FDA has given Abbott's (ABT) 'Absorb fully bioresorbable drug eluting coronary stent' positive review, voting 9 to 0, with one abstention that the...
FierceBiotech  Mar 3  Comment 
Opexa Therapeutics is laying off 30% of its staff to conserve cash as it works through Phase IIb with a multiple sclerosis therapy, hoping to come through with positive results that can extend its runway.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki